Home › Parkinson's Disease › Tennessee
Parkinson's Disease clinical trials in Tennessee
19 studies for Parkinson's Disease are looking for participants at sites in Tennessee.
Cities in Tennessee
A Study of Buntanetap in Participants With PD
- Neurology Clinic, P.C., Cordova
- Veracity Neuroscience LLC, Memphis
RecruitingPhase 2/3
Ages 40 to 85 · All sexes · Updated Sep 21, 2026 · NCT07284784Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT01734122A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #016, Memphis
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Vanderbilt University Medical Center (Site #204), Nashville
RecruitingPhase 2
Ages 30 to 80 · All sexes · Updated Sep 10, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Vanderbilt University, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Veracity Neuroscience, Memphis
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 3, 2026 · NCT07174310A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Vanderbilt University, Nashville
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Aug 28, 2026 · NCT06680830Physiological Brain Atlas Development
- Vanderbilt Univeristy, Nashville
RecruitingObservational study
Ages 6 to 90 · All sexes · Updated Aug 26, 2026 · NCT00575081Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 4Healthy volunteers welcome
Ages 50 to 85 · All sexes · Updated Aug 7, 2026 · NCT05357612A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Aug 4, 2026 · NCT06944522A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- Vanderbilt University (Neurology), Nashville
RecruitingPhase 2
Ages 45 to 75 · All sexes · Updated Jun 29, 2026 · NCT06285643Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 40 and older · All sexes · Updated Jun 12, 2026 · NCT04715984Neurophysiology of Reward Signaling in Parkinson's Disease
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 40 and older · All sexes · Updated Jun 12, 2026 · NCT07409207Natural History Study of Synucleinopathies
- Vanderbilt Univeristy, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT01799915Use of CereGate Therapy for Freezing of Gait in PD
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 21 to 80 · All sexes · Updated May 28, 2026 · NCT05292794Effects of an Independent Walking Program With Walking Poles in People With Parkinson Disease
- East Tennessee State University, Johnson City
Recruiting
All ages · All sexes · Updated Apr 27, 2026 · NCT07551661CPAP for the Treatment of Supine Hypertension
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Recruiting
Ages 40 to 80 · All sexes · Updated Apr 7, 2026 · NCT05489575[18F]F-DOPA Imaging in Patients With Autonomic Failure
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Mar 16, 2026 · NCT04246437Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
RecruitingPhase 1
Ages 40 to 80 · All sexes · Updated Oct 14, 2025 · NCT02897063From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.